99% Purity CAS 206361-99-1 Darunavir API Darunavir Powder Material Darunavir

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Model NO.: Dsung-Darunavir
• Product Name: Darunavir
• Name: Darunavir Powder
• Appearance: off-White Powder
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical Intermediate
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 206361-99-1
• Mf: C27h37n3o7s
• MW: 547.66358
• Einecs No.: 606-590-1
• Density: 1.34
• Melting Point: 74-76 C
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-Sung
• Origin: Shaanxi
• Production Capacity: 2 Ton/Month

Product Description

99% Purity CAS 206361-99-1 Darunavir API Darunavir Powder Material Darunavir

 

Product Description

Product Details

Product Name	Darunavir
CAS No.	206361-99-1
MF	C27H37N3O7S
MW	547.66358
Appearance and shape	Off-white powder

Darunavir is a new kind of used for AIDS treatment of peptide antiretroviral protease inhibitors, is the 6 kinds of protease inhibitors (ShaKui that wei, the wei, indene that wei, naphthalene than the wey, dworkin that wei and ABT378 / r) in the living creature exploitation degree is the highest, by blocking from the infected host cell surface to release the new, the formation process of mature virus particles, suppress the virus protease and work.   When using this product for a long time, often can reduce HIV carriers in the blood, increase the CD4 cell count, reduce the chance of HIV infection, improve the quality of life, prolong life.   Suitable for infected with the AIDS virus but not existing antiretroviral drugs, curative effect of adults, the drug must be with low dose, the wei or other antiretroviral agents used in combination, in order to improve effectiveness.

Application & Function

Function
Darunavir (brand name Prezista, formerly known as TMC114) is a protease inhibitor medication used to treat HIV infection.  Darunavir is an OARAC recommended treatment option for treatment-naïve and treatment-experienced adults and adolescents.
Application
Darunavir was designed to form robust interactions with the protease enzyme from many strains of HIV, including strains from treatment-experienced patients with multiple resistance mutations to PIs.

Specification